DiFUSION Technologies Completes Successful Testing of Antimicrobial Spinal Implant

Share this story with your network

Austin, Texas – January 26, 2009 – DiFUSION Technologies, Inc., a medical device company targeting the orthopaedic market, has successfully completed a series of laboratory tests of its silver ion-based antimicrobial technology designed to mitigate Surgical Site Infections (SSIs) in spinal surgery. The technology will be incorporated into DiFUSION’s first spinal implant CleanFUZE™. Laboratory tests validate the controlled antimicrobial release of ionic silver and antimicrobial efficacy, achieving a 5 log reduction in microbial counts which is 99.999% effective. Currently, no antibiotic can achieve this efficacy.

Leave a Comment

Your email address will not be published. Required fields are marked *